Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible
ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Vakrangee’s distribution network across rural India will help penetrate underserved markets
The consideration for the acquisition is US $ 2.25 million
The company has operations in North America, Asia, and Europe,
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
Subscribe To Our Newsletter & Stay Updated
